Today: 9 June 2026
Browse Category

LSE:ULVR.L 8 December 2025 - 26 February 2026

Unilever share price drops in early London trade as ULVR turns ex-dividend

Unilever share price drops in early London trade as ULVR turns ex-dividend

Unilever shares fell 0.7% to 5,365 pence in early London trading after going ex-dividend, removing entitlement to the 40.52 pence Q4 payout. The record date is Feb. 27, with cash due April 10. Investors are watching for the company’s Q1 trading statement on April 30. Unilever recently forecast 2026 sales growth at the low end of its range and announced a €1.5 billion buyback.
26 February 2026
Unilever share price in focus ahead of London open after India capex plan and broker downgrades

Unilever share price in focus ahead of London open after India capex plan and broker downgrades

Unilever shares closed at 5,320 pence in London, down 8 pence, after broker downgrades and news of a 20 billion rupee investment by Hindustan Unilever in premium manufacturing. Chief R&D Officer Richard Slater sold £1 million in shares. The company warned 2026 sales growth would hit the low end of guidance and announced a €1.5 billion buyback. Q1 results are due April 30.
20 February 2026
Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results

Unilever share price today: ULVR slides in London as tariff nerves linger ahead of results

Unilever shares slipped 0.7% to 4,732.5p in early London trading Tuesday, tracking broader declines in European markets after renewed U.S. tariff threats. Berenberg reiterated its Buy rating and 5,600p target. Investors await Unilever’s Feb. 12 results, the first since the ice cream division demerger, for updates on volumes and margins. Year to date, the stock is down about 2.6%.
20 January 2026
Unilever stock price rises in London despite Trump tariff jitters — what to watch before earnings

Unilever stock price rises in London despite Trump tariff jitters — what to watch before earnings

Unilever shares rose 0.7% to 4,793 pence in early London trading Monday, bucking a 1.3% drop in the STOXX 600 after U.S. President Donald Trump threatened new tariffs tied to Greenland. The company’s next earnings report is set for Feb. 12. Unilever recently spun off its Magnum ice cream unit and completed an 8-for-9 share consolidation.
Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

The FTSE 100 closed down 0.2% at 9,645.09 on Monday, with heavy trading concentrated in BP, Barclays, Rolls-Royce, Unilever, Lloyds, HSBC, London Stock Exchange Group, Anglo American, GSK, and British American Tobacco. Investors pulled back ahead of key US Federal Reserve and Bank of England rate decisions. FTSE 100 futures hovered near 9,657 early Tuesday, with technical signals pointing to caution.
Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

The FTSE 100 closed near 9,660 on December 8, posting a total return of about 20–23% year-to-date, its best run since 2009. The Bank of England has held rates at 4% since August, with inflation at 3.6%. Markets expect a rate cut to 3.75% at the December 18 meeting. UK mortgage rates have dropped to their lowest since before September 2022.

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop